EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe
Steady2 outlets reported this in 2 reports over 2 days
Fri, 16 October 2026Sat, 17 October 2026
What it is about
Pharmaceutical ExecutiveEMAEuropeEli LillyEuropske komisijeOdbor Europske agencije za lijekoveCHMPForbesEuropu
Who published it, and when
original reportfirst to report
Google News - Europe query
Nacional (Croatia)
16 Oct, 13:44over 20 hours17 Oct, 09:24
How it spread - 2 original reports
Fri, 16 October 2026
1 report- Google News - Europe query13:44first to report
EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe Pharmaceutical Executive
Sat, 17 October 2026
1 report- Nacional (Croatia)09:24
Eli Lilly’s Foundayo dobio je zeleno svjetlo od regulatora i sada čeka konačnu odluku Europske komisije. Odbor Europske agencije za lijekove (EMA) za medicinske proizvode za ljudsku upotrebu (CHMP) preporučio je da Foundayo bude odobren za upravljanje težinom i liječenje dijabetesa tipa 2 kod odraslih, prenosi Forbes. Procjena njegove učinkovitosti u upravljanju tjelesnom težinom, prema […]